These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 9556417)
1. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Ferguson AW; Svoboda-Newman SM; Frank TS Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417 [TBL] [Abstract][Full Text] [Related]
2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Fujita M; Inoue M; Tanizawa O; Iwamoto S; Enomoto T Cancer Res; 1992 Oct; 52(19):5323-8. PubMed ID: 1327506 [TBL] [Abstract][Full Text] [Related]
4. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases. Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923 [TBL] [Abstract][Full Text] [Related]
5. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M; Iwasaka T; Matsuo N; Hachisuga T; Mori M; Sugimori H Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix. Waggoner SE; Anderson SM; Van Eyck S; Fuller J; Luce MC; Herbst AL Obstet Gynecol; 1994 Sep; 84(3):404-8. PubMed ID: 8058239 [TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Iwasawa A; Nieminen P; Lehtinen M; Paavonen J Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095 [TBL] [Abstract][Full Text] [Related]
8. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas. Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447 [TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations. Skyldberg BM; Murray E; Lambkin H; Kelehan P; Auer GU Mod Pathol; 1999 Jul; 12(7):675-82. PubMed ID: 10430271 [TBL] [Abstract][Full Text] [Related]
10. Presence of p53 mutation in human cervical carcinomas associated with HPV-33 infection. Lo KW; Mok CH; Chung G; Huang DP; Wong F; Chan M; Lee JC; Tsao SW Anticancer Res; 1992; 12(6B):1989-94. PubMed ID: 1363512 [TBL] [Abstract][Full Text] [Related]
11. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status. Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763 [TBL] [Abstract][Full Text] [Related]
12. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Iwasaka T; Oh-uchida M; Matsuo N; Yokoyama M; Fukuda K; Hara K; Fukuyama K; Hori K; Sugimori H Gynecol Oncol; 1993 Jan; 48(1):104-9. PubMed ID: 8380785 [TBL] [Abstract][Full Text] [Related]
13. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus]. Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698 [TBL] [Abstract][Full Text] [Related]
14. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV. Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694 [TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uterine cervix detected by polymerase chain reaction (PCR). Yamakawa Y; Forslund O; Teshima H; Hasumi K; Kitagawa T; Hansson BG Gynecol Oncol; 1994 May; 53(2):190-5. PubMed ID: 8188078 [TBL] [Abstract][Full Text] [Related]
16. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix. Tenti P; Pavanello S; Padovan L; Spinillo A; Vesentini N; Zappatore R; Migliora P; Zara C; Ranzani GN; Carnevali L Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366 [TBL] [Abstract][Full Text] [Related]
17. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor. Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407 [TBL] [Abstract][Full Text] [Related]
18. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes. Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026 [TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of adenocarcinoma of the cervix. Parker MF; Arroyo GF; Geradts J; Sabichi AL; Park RC; Taylor RR; Birrer MJ Gynecol Oncol; 1997 Feb; 64(2):242-51. PubMed ID: 9038270 [TBL] [Abstract][Full Text] [Related]
20. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK; Kannan K; Bhuvarahamurthy V; Ishida I; Fujinaga K; Tsuchida N; Shanmugam G Gynecol Oncol; 1998 Jun; 69(3):205-9. PubMed ID: 9648588 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]